Full-Component Chart-Derived Lee Score, Upfront Androgen Receptor Signaling Inhibitor Selection, and Competing Mortality in Metastatic Hormone-Sensitive Prostate Cancer. [PDF]
Geriatr Gerontol IntKurokawa K +5 more
europepmc +1 more source
A systematic review and meta-analysis of treatment-induced hypertension risks from androgen receptor pathway inhibitors in randomized controlled trials for prostate cancer. [PDF]
BMC CancerGong Q, Ge F, Chen T.
europepmc +1 more source
An Update on the Role of Androgens and Androgen Receptor in Triple-Negative Breast Cancer. [PDF]
CellsCortes BC +3 more
europepmc +1 more source
PRO/CON debate: nonsteroidal versus steroidal mineralocorticoid receptor antagonists in chronic kidney disease: progress, pragmatism, and remaining uncertainties. [PDF]
Clin Kidney JAgarwal R, Vogt L, Floege J, Zoccali C.
europepmc +1 more source
Induced proximity-based therapeutics for advanced prostate cancer. [PDF]
NPJ Drug DiscovChing J, Chau CH, Figg WD.
europepmc +1 more source
The intricate interplay between circadian rhythm, androgen signaling, hormone therapy, and cellular senescence in prostate cancer. [PDF]
Cancer Metastasis RevHeidari Horestani M, Baniahmad A.
europepmc +1 more source
Glutamate Ionotropic Kainate Receptors as Therapeutic Targets in Enzalutamide-Resistant and Neuroendocrine Prostate Cancer. [PDF]
Int J Mol SciQu H +13 more
europepmc +1 more source
Efficacy, Safety, and Cost-Effectiveness of Reduced versus Full Initial Doses of Androgen Receptor Signaling Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective Study. [PDF]
ProstateAsanuma H +18 more
europepmc +1 more source
Diet-Induced Obesity Promotes Alopecia Through Oxidative Stress and Androgen Signalling in Female Mice. [PDF]
Exp DermatolTu YA +5 more
europepmc +1 more source